“…Overall, because our approach is easy-to-implement (especially through the treatment using the initial velocity), it may represent an interesting method for the development of additional new drug-actinometers. In fact, it has thus far allowed us to propose four new accurate actinometers covering the whole spectrum of light, namely, NIS (320-400 nm), nifedipine (280-400 nm) [3], montelukast (258-380 nm) [5], fluvoxamine (260-290 nm) [6], sunitinib (320-480) [7], and 1,2-bis [2-methylbenzo[b] thiophen-3,3,4,4,5,5-hexafluoro-1-cyclopentene, DAE, for the visible 405-570 nm region [2].…”